LLS30 is an allosteric inhibitor of Galectin-1 (Gal-1). LLS30 inhibits the downstream MEK/ERK signaling pathway and also inhibits Akt phosphorylation. LLS30 exhibits potent proliferation-inhibitory activity against various prostate cancer cell lines.
Molecular Weight:
701.47
CAS Number:
[2138367-58-3]
Formula:
C34H33Cl4N5O3
Target:
Galectin
T69874
T69874
* VAT and and shipping costs not included. Errors and price changes excepted
